FOXI2: a possible gene contributing to ectodermal dysplasia

Eur J Dermatol. 2017 Dec 1;27(6):641-645. doi: 10.1684/ejd.2017.3130.

Abstract

Cardio-facio-cutaneous syndrome (CFC), Noonan syndrome (NS), and Costello syndrome are a group of diseases that belong to the RASopathies. The syndromes share clinical features making diagnosis a challenge. To investigate the phenotype and genotype of a 10-year-old Iraqi girl with overlapping features of CFC, NS, and Costello syndromes, with additional features of ectodermal dysplasia. DNA was examined by exome sequencing and protein expression by immunohistochemistry. Exome sequencing identified a mutation in the SOS1 gene and a de novo deletion in the FOXI2 gene which was neither present in the international databases, nor in 400 chromosomes from the same population. Based on immunohistochemical staining, FOXI2 was identified in the basal cell layer of the skin and overlapped with the expression of P63, a major player in ectodermal dysplasia. We therefore suggest screening for FOXI2 mutation in the setting of ectodermal features that are not associated with genes known to contribute to ectodermal dysplasia.

Keywords: FOXI2; Noonan syndrome; RAS; SOS1; cardio-facio-cutaneous syndrome.

MeSH terms

  • Child
  • Costello Syndrome / diagnosis
  • Costello Syndrome / genetics
  • Ectodermal Dysplasia / diagnosis
  • Ectodermal Dysplasia / genetics*
  • Ectodermal Dysplasia / pathology
  • Facies
  • Failure to Thrive / diagnosis
  • Failure to Thrive / genetics
  • Female
  • Heart Defects, Congenital / diagnosis
  • Heart Defects, Congenital / genetics
  • Humans
  • Mutation*
  • Noonan Syndrome / diagnosis
  • Noonan Syndrome / genetics
  • SOS1 Protein
  • Transcription Factors / genetics
  • Tumor Suppressor Proteins / genetics

Substances

  • SOS1 Protein
  • TP63 protein, human
  • Transcription Factors
  • Tumor Suppressor Proteins

Supplementary concepts

  • Cardiofaciocutaneous syndrome